These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 24284112)
1. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus. Gray J; Fullarton GM Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Foroulis CN; Thorpe JA Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma. Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964 [TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus. Dunn JM; Mackenzie GD; Banks MR; Mosse CA; Haidry R; Green S; Thorpe S; Rodriguez-Justo M; Winstanley A; Novelli MR; Bown SG; Lovat LB Lasers Med Sci; 2013 May; 28(3):707-15. PubMed ID: 22699800 [TBL] [Abstract][Full Text] [Related]
7. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Panjehpour M; Overholt BF Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M; Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958 [TBL] [Abstract][Full Text] [Related]
9. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080 [TBL] [Abstract][Full Text] [Related]
10. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia. Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171 [TBL] [Abstract][Full Text] [Related]
11. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M; Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436 [TBL] [Abstract][Full Text] [Related]
12. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Yachimski P; Puricelli WP; Nishioka NS Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia. Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901 [TBL] [Abstract][Full Text] [Related]
14. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650 [TBL] [Abstract][Full Text] [Related]
15. Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus. van Hillegersberg R; Haringsma J; ten Kate FJ; Tytgat GN; van Lanschot JJ Dig Surg; 2003; 20(5):440-4. PubMed ID: 12900536 [TBL] [Abstract][Full Text] [Related]
16. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer]. Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy. Davila ML Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498 [TBL] [Abstract][Full Text] [Related]
19. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482 [TBL] [Abstract][Full Text] [Related]
20. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Prasad GA; Wang KK; Buttar NS; Wongkeesong LM; Lutzke LS; Borkenhagen LS Gastrointest Endosc; 2007 Jan; 65(1):60-6. PubMed ID: 17185080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]